DETECTION OF MINIMAL RESIDUAL DISEASE IN LYMPHOID MALIGNANCIES
    1.
    发明申请
    DETECTION OF MINIMAL RESIDUAL DISEASE IN LYMPHOID MALIGNANCIES 审中-公开
    检测淋巴细胞恶性疾病中的最小残留病

    公开(公告)号:WO9914366A3

    公开(公告)日:1999-05-06

    申请号:PCT/NL9800542

    申请日:1998-09-18

    CPC classification number: C12Q1/6886 C12Q2600/118

    Abstract: The invention relates to the field of cancer diagnosis, more specific to the monitoring of disease development during and after treatment. The invention comprises a method for determining minimal residual disease comprising amplifying nucleic acid molecules using at least one primer reactive with a common gene segment and further comprising identifying malignancy-specific nucleic acid sequences by hybridising with a fluorogenic probe specifically and selectively reactive with said malignancy-specific nucleic acid sequences.

    Abstract translation: 本发明涉及癌症诊断领域,更具体地涉及治疗期间和治疗后疾病发展的监测。 本发明包括用于确定最小残留疾病的方法,其包括使用至少一种与共同基因片段反应的引物扩增核酸分子,并且还包括通过与荧光探针杂交鉴定恶性肿瘤特异性核酸序列,并与所述恶性肿瘤特异性选择性反应, 特异性核酸序列。

    VECTOR VACCINES OF RECOMBINANT FELINE HERPESVIRUS
    2.
    发明申请
    VECTOR VACCINES OF RECOMBINANT FELINE HERPESVIRUS 审中-公开
    重组人肝炎病毒的载体疫苗

    公开(公告)号:WO1994003621A1

    公开(公告)日:1994-02-17

    申请号:PCT/EP1993001971

    申请日:1993-07-23

    Inventor: AKZO N.V.

    Abstract: The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into a section of the FHV genome. The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a heterologous polypeptide derived from a feline pathogen and induces an adequate immune response in an inoculated host against both FHV and the feline pathogen.

    Abstract translation: 本发明涉及包含引入FHV基因组部分的异源基因的猫疱疹病毒(FHV)突变体。 本发明还涉及包含这样的FHV突变体的载体疫苗,其表达源自猫科病原体的异源多肽,并且在接种的宿主中对FHV和猫病原体诱导足够的免疫应答。

Patent Agency Ranking